PPBT
Purple Biotech
PPBT
PPBT
12 hedge funds and large institutions have $3.72M invested in Purple Biotech in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less funds holding
Funds holding: 15 → 12 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
12
Holding in Top 10
–
Calls
$1.98M
Puts
$1.5M
Top Buyers
| 1 | +$2.56M | |
| 2 | +$155K | |
| 3 | +$134K | |
| 4 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$102K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.6K |
Top Sellers
| 1 | -$905K | |
| 2 | -$632K | |
| 3 | -$179K | |
| 4 |
VF
Virtu Financial
New York
|
-$89K |
| 5 |
O
OrbiMed
New York
|
-$66.5K |